3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Active not recruiting
5
Completed
2
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
19
Breast Neoplasms
12
Lung Neoplasms
10
Brain Neoplasms
9
Glioblastoma
7
Neoplasm Metastasis
6
Neoplasms
5
Glioma
5
Carcinoma, Renal Cell
5
Carcinoma, Non-Small-Cell Lung
5
Sarcoma
4
Pancreatic Neoplasms
4
Head and Neck Neoplasms
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Mycosis Fungoides
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Liver Neoplasms
3
Gliosarcoma
3
Waldenstrom Macroglobulinemia
2
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Sezary Syndrome
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neuroendocrine Tumors
2
Interventions
thymoglobulin
2
Thiotepa
2
Stem Cell Transplantation
2
Melphalan
2
Ifosfamide
2
Etoposide
2
Bone Marrow Transplantation
2
Antilymphocyte Serum
2
sodium thiosulfate
1
ribociclib
1
omburtamab I-131
1
lexatumumab
1
ganitumab
1
fludarabine phosphate
1
copanlisib
1
bempegaldesleukin
1
X-Rays
1
Vincristine
1
Topotecan
1
Temozolomide
1
Tacrolimus
1
Specimen Handling
1
Rituximab
1
Receptor Protein-Tyrosine Kinases
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Polymerase Chain Reaction
1
Platinum
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Rhabdomyosarcoma
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled